Heart Failure Society of America Inc

Annual Scientific Meeting:Professionals gather annually to present and discuss cutting edge research, gain advanced education, and discuss new treatments. The 2024 Annual Scientific meeting was cancelled due to Hurricane Helene. Prior to cancellation, the meeting was planned to feature three plenary sessions, 49 sessions, five kick off sessions, four how-to sessions, one pre-meeting workshop, four Professionals in Training talks, six Research Hub talks, six roundtable sessions, four JCF sessions, 11 satellite programs, six forums, eight industry expert theaters, and over 500 abstracts and 2,371 attendees registered.

Education and Programs: Programs aimed at education for the entire heart failure team, including cardiologists, nurses, pharmacists, physician assistants, etc., Initiatives include the Heart Failure Seminars, AHFTC Board Certification Review Course, CardioBites, and Heart Failure Certification (HF-Cert) Bootcamp.Seminars In 2024, the HFSA Heart Failure Seminar series highlighted a wide spectrum of heart failure topics, addressing educational gaps within the heart failure provider community and aligning with HFSAs 2024 scientific statements. Topics included iron deficiency, GDMT, advanced heart failure, myocarditis, cognitive impairment, and HFSA HF Stats. These seminars drew a multidisciplinary audience of physicians (MD/DO), nurse practitioners and registered nurses (APRN/NP/RN), pharmacists (PharmD/RPh), physician assistants (PA-C), and other healthcare professionals, with an average registration of approximately 160 participants per session. Overall, attendees consistently praised the expert speakers, engaging presentations, and the sessions practical applicability to patient care, noting that the content was valuable, relevant, and well organized. AHFTC Board Certification Review Course2024 marked the return of the in-person HFSA AHFTC Board Certification Review Course, held July 1214, 2024, in Chicago, Illinois. The course is designed to help physicians prepare for initial certification or recertification for the ABIM Advanced Heart Failure and Transplant Cardiology Board Certification and Maintenance of Certification exam. For those not preparing for the exam, the program offers a comprehensive and specialized learning experience, providing an in-depth update and review of heart failure. The in-person course had over 125 registered attendees, who described it as highly informative and excellent. Following the live event, the course remained available in the HFSA Learning Center as an OnDemand product, allowing those unable to attend in person to study at their own pace. Feedback continues to be overwhelmingly positive, with many participants noting that the course has been invaluable for their practice and ongoing professional development.CardioBitesHFSA continued and expanded the CardioBites program. CardioBites is a micro-learning program that is targeted to the busy heart failure care team to provide information on one topic in a three-minute video. Two series initially launched in 2023 were completed in 2024. The Amyloidosis nine-part series had five modules released in 2024 How is Amyloidosis diagnosed? Treatment and Management of Immunoglobulin Light Chain (AL) Amyloidosis; Treatment and Management of Transthyretin-mediated (ATTR) Amyloidosis; Multidisciplinary Amyloidosis; and Amyloidosis: Treatments on the Horizon. The HFpEF 4 module series completed its final module in 2024, posting its final module, What do current guidelines recommend for the treatment of HFpEF? Three new CardioBites series were also launched in 2024: SGLT2is, Inflammation, and Congestion. SGLT2is was a five-part module that also included a new product in the CardioBite line: Cardio Infographic, a graphic covering the scope of the series. The SGLT2is modules included: Understanding the burden of heart failure; Current guidelines on the use of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2is) in HF; The Impact of Hospital Readmissions on Health-Related Quality of Life in Heart Failure; Improving the Transition of Care in Heart Failure; Why guideline-directed medical therapy in heart failure matters. The Inflammation CardioBites series posted its first of four modules, What is the role of systemic inflammation in ASCVD and heart failure?. The Congestion CardioBites series posted its first of four modules, What is congestion in heart failure?HF-Cert Bootcamp HFSA added CE to its three 90-minute HF-Cert Bootcamp webinars. These three seminars offered a comprehensive study tool for the HF-Cert examination. Joint Accreditation RecertificationIn 2024, HFSA achieved a four-year recertification from Joint Accreditation for Interprofessional Continuing Education. This distinction recognizes HFSAs dedication to providing education for the entire heart failure care teamincluding physicians, nurses, pharmacists, and other healthcare professionals, through programs that meet the highest standards of quality and collaboration. Joint Accreditation ensures HFSA can continue delivering evidence-based, team-focused education that supports improved patient outcomes and advances the field of heart failure care. 2024 Accredited Educational ImpactIn 2024, HFSA delivered 33 accredited educational activities9 live courses, 22 enduring materials, and 2 manuscript reviewsengaging a total of 2,305 participants across the heart failure care team. These programs provided accessible, high-quality learning opportunities designed to enhance skills, foster collaboration, and ultimately improve patient outcomes.